ES2001099A6 - Procedimiento para la preparacion de una composicion farmaceutica a base de fosfolipidos. - Google Patents

Procedimiento para la preparacion de una composicion farmaceutica a base de fosfolipidos.

Info

Publication number
ES2001099A6
ES2001099A6 ES8601163A ES8601163A ES2001099A6 ES 2001099 A6 ES2001099 A6 ES 2001099A6 ES 8601163 A ES8601163 A ES 8601163A ES 8601163 A ES8601163 A ES 8601163A ES 2001099 A6 ES2001099 A6 ES 2001099A6
Authority
ES
Spain
Prior art keywords
appropriate
pharmaceutically acceptable
phospholipid
alkylene
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8601163A
Other languages
English (en)
Inventor
Alan J Schroit
Rajiv Nayar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of ES2001099A6 publication Critical patent/ES2001099A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR COMPOSICIONES FARMACEUTICAS A BASE DE FOSFOLIPIDOS POR MEZCLA DE UN FOSFOLIPIDO SINTETICO DE FORMULA I CON UN FOSFOLIPIDO DE FORMULA II EN LOS QUE LOS DIVERSOS RESTOS Y SUSTITUYENTES TIENEN LOS SIGNIFICADOS EN LA DESCRIPCION, UN COMPUESTO O UNA MEZCLA DE COMPUESTOS QUE TIENEN ACTIVIDAD FARMACOLOGICA; Y, OPCIONALMENTE, CON UN FOSFOLIPIDO DE ORIGEN NATURAL, OPCIONALMENTE CON UNA SOLUCION VEHICULO FARMACEUTICAMENTE ACEPTABLE TAMPONADA A PH 7-7,9 Y, OPCIONALMENTE, VEHICULOS FARMACEUTICAMENTE ACEPTABLES EN FORMA SOLIDA.
ES8601163A 1985-08-19 1986-08-18 Procedimiento para la preparacion de una composicion farmaceutica a base de fosfolipidos. Expired ES2001099A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76662585A 1985-08-19 1985-08-19

Publications (1)

Publication Number Publication Date
ES2001099A6 true ES2001099A6 (es) 1988-04-16

Family

ID=25077017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8601163A Expired ES2001099A6 (es) 1985-08-19 1986-08-18 Procedimiento para la preparacion de una composicion farmaceutica a base de fosfolipidos.

Country Status (18)

Country Link
EP (1) EP0213523B1 (es)
JP (1) JPS6296431A (es)
KR (1) KR870001838A (es)
AT (1) ATE59002T1 (es)
AU (1) AU591162B2 (es)
CA (1) CA1273575A (es)
DD (1) DD248736A5 (es)
DE (1) DE3676133D1 (es)
DK (1) DK165314C (es)
ES (1) ES2001099A6 (es)
FI (1) FI863311A (es)
GR (1) GR862144B (es)
HU (1) HU206045B (es)
NO (1) NO171886C (es)
NZ (1) NZ217239A (es)
PH (1) PH26160A (es)
PT (1) PT83204B (es)
ZA (1) ZA866200B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256989A1 (en) * 1986-08-18 1988-02-24 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
DK86988A (da) * 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd Liposompraeparat og anvendelse deraf
AU7496991A (en) * 1990-03-20 1991-10-21 Otsuka Pharmaceutical Co., Ltd. Liposome preparation
DE69429511T2 (de) * 1993-05-21 2002-05-16 Liposome Co Inc Reduzierung von durch liposome induzierte physiologischen gegenreaktionen
PT785773E (pt) * 1994-10-14 2001-05-31 Liposome Co Inc Lipossomas de eteres lipidicos e sua utilizacao terapeutica
US7306784B2 (en) 1998-06-20 2007-12-11 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US6589503B1 (en) 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US8038984B2 (en) 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US7803351B2 (en) 2004-08-20 2010-09-28 Washington University Blood brain barrier permeation peptides
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2019043026A1 (en) 2017-08-30 2019-03-07 INSERM (Institut National de la Santé et de la Recherche Médicale) ANTI-MESOTHELIC RADIOMARQUATED SINGLE DOMAIN ANTIBODIES SUITABLE FOR IMAGING AND TREATING CANCERS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3218027A1 (de) * 1982-05-13 1983-11-17 A. Nattermann & Cie GmbH, 5000 Köln Phospholipidloesungen

Also Published As

Publication number Publication date
NZ217239A (en) 1989-09-27
DK165314C (da) 1993-03-29
DK392786A (da) 1987-02-20
PH26160A (en) 1992-03-18
DK392786D0 (da) 1986-08-18
KR870001838A (ko) 1987-03-28
JPS6296431A (ja) 1987-05-02
ATE59002T1 (de) 1990-12-15
FI863311A (fi) 1987-02-20
HUT41634A (en) 1987-05-28
EP0213523A3 (en) 1987-10-14
EP0213523B1 (de) 1990-12-12
PT83204A (en) 1986-09-01
AU591162B2 (en) 1989-11-30
HU206045B (en) 1992-08-28
ZA866200B (en) 1987-03-25
DE3676133D1 (de) 1991-01-24
NO171886B (no) 1993-02-08
FI863311A0 (fi) 1986-08-15
DD248736A5 (de) 1987-08-19
EP0213523A2 (de) 1987-03-11
NO171886C (no) 1993-05-19
NO863315L (no) 1987-02-20
DK165314B (da) 1992-11-09
PT83204B (pt) 1989-03-30
NO863315D0 (no) 1986-08-18
AU6155686A (en) 1987-02-26
GR862144B (en) 1986-12-23
CA1273575A (en) 1990-09-04

Similar Documents

Publication Publication Date Title
ES2001099A6 (es) Procedimiento para la preparacion de una composicion farmaceutica a base de fosfolipidos.
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
NZ223262A (en) 11-arylestra-4,9-dien-3-ones, derivatives and pharmaceutical compositions
HUT35957A (en) Process for producing phosholipide compositions and pharmaceutical compositions containing them as active agents
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
AU5791190A (en) New peptide derivatives, process for preparing them and pharmaceutical compositions containing them
ES8403928A1 (es) Un procedimiento para la preparacion de nuevas macrolidas antibioticas.
FI834702A0 (fi) Nya nitroalifatiska foereningar, deras framstaellningsfoerfarande och anvaendning
IL87254A0 (en) Stable oxapenem-3-carboxylic acids,their preparation and pharmaceutical compositions containing them
NZ222741A (en) Pharmaceutical compositions containing an interferon and a purine derivative
ES8205224A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilios 6-1-y 2-sustituidos.
GB2152508A (en) Pyrimidine derivatives
ES2087421T3 (es) Acidos (1's)-hidroxialquiloxapenem-3-carboxilicos y su uso como inhibidor de la betalactamasa.
RU94042399A (ru) Получения клавулановой кислоты из соли клавулановой кислоты и амина, соли клавулановой кислоты и амина
PT86422A (fr) Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant
JO1871B1 (en) Innovative substituted benzimidazole compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102